T619-3231 Screening compound: {5-[1-{[3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl]methyl}tetrahydro-2(2H)-pyridinyl]-1,2,4-oxadiazol-3-yl}methyl methyl ether

T619-3231 Screening compound: {5-[1-{[3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl]methyl}tetrahydro-2(2H)-pyridinyl]-1,2,4-oxadiazol-3-yl}methyl methyl ether
T619-3231 Screening compound: {5-[1-{[3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl]methyl}tetrahydro-2(2H)-pyridinyl]-1,2,4-oxadiazol-3-yl}methyl methyl ether alternative view

Chemical Structure Depiction of ChemDiv screening compound T619-3231
{5-[1-{[3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl]methyl}tetrahydro-2(2H)-pyridinyl]-1,2,4-oxadiazol-3-yl}methyl methyl ether

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T619-3231

Molecular Formula

C15H23N5O4 (C15 H23 N5 O4)

Compound Name

{5-[1-{[3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl]methyl}tetrahydro-2(2H)-pyridinyl]-1,2,4-oxadiazol-3-yl}methyl methyl ether

IUPAC name

n/a

SMILES

COCCc1noc(CN(CCCC2)C2c2nc(COC)no2)n1

InChI

InChI=1S/C15H23N5O4/c1-21-8-6-12-16-14(23-18-12)9-20-7-4-3-5-11(20)15-17-13(10-22-2)19-24-15/h11H,3-10H2,1-2H3/t11-/m0/s1

InChI Key

WCYJEXQOSMFLNE-NSHDSACASA-N

MDL Number (MFCD)

MFCD29033327

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

337.38

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.062

Distribution Coefficient, logD

1.049

Water Solubility, LogSw

-1.03

Polar Surface Area

85.870

Acid Dissociation Constant (pKa)

27.43

Base Dissociation Constant (pKb)

5.89

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

73.30

T619-3231 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with T619-3231 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T619-3231?
Check Price and Availability of T619-3231, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T619-3231 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T619-3231
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T619-3231
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T619-3231 available by request